Home/Pipeline/Doxorubicin Liposome

Doxorubicin Liposome

Ovarian Cancer

Phase 3Active

Key Facts

Indication

Ovarian Cancer

Phase

Phase 3

Status

Active

Company

CSPC Pharmaceutical Group Limited

About CSPC Pharmaceutical Group Limited

CSPC Pharmaceutical Group is a leading Chinese pharmaceutical company with a diversified portfolio spanning innovative drug development, generic medicines, and pharmaceutical manufacturing. Founded in 1997 and publicly traded on the Hong Kong Stock Exchange, the company has established itself as a major player in China's pharmaceutical industry with strong R&D capabilities and extensive manufacturing infrastructure. CSPC focuses primarily on oncology, CNS disorders, and metabolic diseases, with multiple products in clinical development and a robust commercial portfolio serving both domestic and international markets.

View full company profile

Therapeutic Areas

Oncology Central Nervous System Metabolic Diseases Nephrology Respiratory

Other Ovarian Cancer Drugs

Drug	Company	Phase	Status
TTFields	Novocure	Phase 3	Active (INNOVATE-3 trial)
Selinexor	Karyopharm Therapeutics	Clinical Trials	Investigational
Measovir®-based candidate	Oncovita	Pre-clinical	Preclinical activity demonstrated